4/9
09:37 am
abt
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [Yahoo! Finance]
Low
Report
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [Yahoo! Finance]
4/9
09:21 am
abt
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [TheStreet.com]
Low
Report
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [TheStreet.com]
4/9
09:00 am
abt
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
Low
Report
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health
4/8
10:17 am
abt
Abbott Laboratories (ABT) had its price target raised by Barclays PLC from $142.00 to $144.00. They now have an "overweight" rating on the stock.
Low
Report
Abbott Laboratories (ABT) had its price target raised by Barclays PLC from $142.00 to $144.00. They now have an "overweight" rating on the stock.
4/8
09:21 am
abt
Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $140.00 to $121.00. They now have a "buy" rating on the stock.
Low
Report
Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $140.00 to $121.00. They now have a "buy" rating on the stock.
4/7
11:42 pm
abt
Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness [Yahoo! Finance]
4/7
09:20 am
abt
Abbott Laboratories (ABT) had its price target lowered by Evercore Inc from $138.00 to $134.00. They now have an "outperform" rating on the stock.
Low
Report
Abbott Laboratories (ABT) had its price target lowered by Evercore Inc from $138.00 to $134.00. They now have an "outperform" rating on the stock.
4/5
09:54 am
abt
The Best Dividend ETF to Buy in April 2026 If You Want Passive Income [Yahoo! Finance]
Low
Report
The Best Dividend ETF to Buy in April 2026 If You Want Passive Income [Yahoo! Finance]
4/4
01:07 am
abt
Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come? [Yahoo! Finance]
Low
Report
Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come? [Yahoo! Finance]
4/1
10:12 pm
abt
????????????????:2026???2036????CAGR10.01%?50.8??????????? [CNET News]
Low
Report
????????????????:2026???2036????CAGR10.01%?50.8??????????? [CNET News]
4/1
01:08 pm
abt
Abbott: A Brighter Investment Case Heading Into Q1 Earnings (Rating Upgrade) [Seeking Alpha]
Low
Report
Abbott: A Brighter Investment Case Heading Into Q1 Earnings (Rating Upgrade) [Seeking Alpha]
4/1
06:50 am
abt
Whoop concludes $575m fundraise, adding Abbott as strategic investor [Yahoo! Finance]
Low
Report
Whoop concludes $575m fundraise, adding Abbott as strategic investor [Yahoo! Finance]
4/1
01:52 am
abt
This Dividend King Is Down 26%. When Will It Bounce Back? [Yahoo! Finance]
Low
Report
This Dividend King Is Down 26%. When Will It Bounce Back? [Yahoo! Finance]
3/31
05:45 pm
abt
WHOOP Health Platform Gets Glitzy Investors, Makes Big Promises [Yahoo! Finance]
Low
Report
WHOOP Health Platform Gets Glitzy Investors, Makes Big Promises [Yahoo! Finance]
3/31
05:27 pm
abt
WHOOP Health Platform Gets Glitzy Investors, Makes Big Promises [Forbes]
Low
Report
WHOOP Health Platform Gets Glitzy Investors, Makes Big Promises [Forbes]
3/31
04:49 pm
abt
Whoop Raises $575 Million at $10.1 Billion Valuation, Reports 103% Growth [Yahoo! Finance]
Low
Report
Whoop Raises $575 Million at $10.1 Billion Valuation, Reports 103% Growth [Yahoo! Finance]
3/31
08:02 am
abt
Abbott Laboratories (ABT) had its price target lowered by BTIG Research from $140.00 to $131.00. They now have a "buy" rating on the stock.
Low
Report
Abbott Laboratories (ABT) had its price target lowered by BTIG Research from $140.00 to $131.00. They now have a "buy" rating on the stock.
3/30
07:45 pm
abt
Abbott (ABT) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]
Low
Report
Abbott (ABT) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]
3/30
02:37 pm
abt
Will Integrating Precision Oncology Tests into OncoEMR Change Abbott Laboratories' (ABT) Narrative? [Yahoo! Finance]
Low
Report
Will Integrating Precision Oncology Tests into OncoEMR Change Abbott Laboratories' (ABT) Narrative? [Yahoo! Finance]
3/30
09:00 am
abt
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
Low
Report
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
3/27
06:12 am
abt
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends [Yahoo! Finance]
Low
Report
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends [Yahoo! Finance]
3/26
09:00 am
abt
Abbott hosts conference call for first-quarter earnings
Low
Report
Abbott hosts conference call for first-quarter earnings
3/24
06:29 pm
abt
Is It Time To Reconsider Abbott Laboratories (ABT) After Recent Share Price Weakness? [Yahoo! Finance]
Low
Report
Is It Time To Reconsider Abbott Laboratories (ABT) After Recent Share Price Weakness? [Yahoo! Finance]
3/24
08:00 am
abt
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
Low
Report
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
3/24
07:50 am
abt
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results [Yahoo! Finance]
Low
Report
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results [Yahoo! Finance]